Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide

Journal of Hospital Infection

Volumn 81, Issue 4, 2012, Pages 239-245

  Chmielarczyk, A ^a   Higgins, P G ^b   Wojkowska Mach, J ^a   Synowiec, E ^c   Zander, E ^b   Romaniszyn, D ^a   Gosiewski, T ^a   Seifert, H ^b   Heczko, P ^a   Bulanda, M ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Hospital acquired infection; Multidrug resistant Acinetobacter baumannii; Outbreak; Vaporized hydrogen peroxide

Indexed keywords

AMIKACIN; CARBAPENEM; CARBAPENEMASE; CIPROFLOXACIN; GENTAMICIN; HYDROGEN PEROXIDE; IMIPENEM; MEROPENEM; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; DISINFECTION; EPIDEMIC; EPSILOMETER TEST; FEMALE; GENOTYPE; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CROSS INFECTION; DISEASE OUTBREAKS; DISINFECTANTS; DISINFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; HYDROGEN PEROXIDE; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; VOLATILIZATION;

EID: 84863875062     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.05.010     Document Type: Article

References (32)

1. Levin A.S., Gobara S., Mendes C.M., Cursino M.R., Sinto S. Environmental contamination by multidrug-resistant Acinetobacter baumannii in an intensive care unit. Infect Control Hosp Epidemiol 2001, 22:717-720.
2. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
3. Villegas M.V., Hartstein A.I. Acinetobacter outbreaks 1977-2000. Infect Control Hosp Epidemiol 2003, 24:284-295.
4. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5:939-951.
5. Young L.S., Sabel A.L., Price C.S. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect Control Hosp Epidemiol 2007, 28:1247-1254.
6. LaForgia C., Franke J., Hacek D.M., Thomson R.B., Robicsek A., Peterson L.R. Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: a 38-month report. Am J Infect Control 2010, 38:259-263.
7. Falagas M.E., Thomaidis P.C., Kotsantis I.K., Sgouros K., Samonis G., Karageorgopoulos D.E. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect 2011, 78:171-177.
8. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
9. Higgins P.G., Wisplinghoff H., Krut O., et al. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect 2007, 13:1199-1201.
10. Leclercq R., Cantón R., Brown D.F., et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2012, March 29 [E-pub ahead of print]. 10.1111/j.1469-0691.2011.03703.x.
11. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement. Document M100-S21 2011, CLSI, Wayne, PA.
12. AB bioMérieux. Summary of Etest performance, interpretative criteria and quality control ranges - Table 1. AB bioMérieux Document 2009; 05, Solna.
13. Woodford N., Ellington M.J., Coelho J.M., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006, 27:351-353.
14. Turton J.F., Ward M.E., Woodford N., et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006, 258:72-77.
15. Higgins P.G., Dammhayn C., Hackel M., et al. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010, 65:233-238.
16. Seifert H., Dolzani L., Bressan R., et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005, 43:4328-4335.
17. SHEA/IDSA practice recommendation strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29:S31-S40.
18. Boyce J.M., Pittet D. Healthcare Infection Control Practices Advisory Committee. Society for Healthcare Epidemiology of America. Association for Professionals in Infection Control. Infectious Diseases Society of America. Hand Hygiene Task Force: Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002, 23(12 Suppl.):S3-40.
19. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007, 12:S65-164.
20. Sax H., Allegranzi B., Uçkay I., Larson E., Boyce J., Pittet D. 'My five moments for hand hygiene': a user-centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect 2007, 67:9-21.
21. Luna C.M., Aruj P.K. Nosocomial Acinetobacter pneumonia. Respirology 2007, 2:787-791.
22. Dizbay M., Altuncekic A., Sezer B.E., Ozdemir K., Arman D. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. Int J Antimicrob Agents 2008, 32:29-32.
23. Markogiannakis A., Fildisis G., Tsiplakou S., et al. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit. Infect Control Hosp Epidemiol 2008, 29:410-417.
24. D'Arezzo S., Capone A., Petrosillo N., et al. Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). Clin Microbiol Infect 2009, 15:347-357.
25. Falagas M.E., Kopterides P., Siempos I.I. Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis 2006, 43:389.
26. Van Looveren M., Goossens H. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 2004, 10:684-704. ARPAC Steering Group.
27. Sader H.S., Farrell D.J., Jones R.N. Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009). Diagn Microbiol Infect Dis 2011, 69:223-227.
28. Pachón J., Vila J. Treatment of multiresistant Acinetobacter baumannii infections. Curr Opin Investig Drugs 2009, 10:150-156.
29. Wróblewska M.M., Towner K.J., Marchel H., Luczak M. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland. Clin Microbiol Infect 2007, 13:490-496.
30. Valenzuela J.K., Thomas L., Partridge S.R., van der Reijden T., Dijkshoorn L., Iredell J. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol 2007, 45:453-460.
31. Hardy K.J., Gossain S., Henderson N., et al. Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 2007, 66:360-368.
32. Ray A., Perez F., Beltramini A.M., et al. Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant Acinetobacter baumannii infection at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010, 31:1236-1241.